Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Stereotaxis, Inc. (STXS)

« Back to company index

STXS Chatter Timeline

Stock Ticker for STXS

Most Active Tweeters for STXS

UserTweets
@ErikaWeis1 16
@Gambiste1 4
@fintel_io 2
@TheTradeXchange 2
@StockWolfCom 2

Recent Tweets for STXS

dakotafinancial @dakotafinancial
Stereotaxis $STXS Shares Up 11.4% https://t.co/ky7BkTBZ7P
November 15th 2019, 10:11pm
mtropea08 @mtropea08
RT @Stereotaxis: “We are pleased with the methodical progress across all aspects of Stereotaxis” https://t.co/VBQrLXFEdY #RoboticEP $STXS #…
November 14th 2019, 9:11pm
SiteFocusHQ @SiteFocusHQ
$STXS Earnings Intelligence Analysis of recent earnings identified Stereotaxis, Inc. (STXS) business focus on (euro… https://t.co/NI1v7xHJ8w
November 14th 2019, 4:11pm
finalexecutive @finalexecutive
$STXS - Stereotaxis, Inc. (STXS) final boss David Fischel on Q3 2019 Results - Earnings Call Transcript. Continue reading:….
November 14th 2019, 4:11pm
SeekingAlpha @SeekingAlpha
$STXS - Stereotaxis, Inc. (STXS) CEO David Fischel on Q3 2019 Results - Earnings Call Transcript. Continue reading:… https://t.co/DjgQQaNpNc
November 14th 2019, 4:11pm
fintel_io @fintel_io
$STXS / Stereotaxis files form 10-Q https://t.co/xsASDnH26X
November 14th 2019, 12:11pm
medtechy @medtechy
Stereotaxis Reports 2019 Third Quarter Financial Results $STXS | Medtechy https://t.co/qcB6ghdlSf
November 14th 2019, 10:11am
otcdynamics @otcdynamics
$STXS Stereotaxis Reports 2019 Third Quarter Financial Results https://t.co/Yo0v2MUK5H
November 14th 2019, 8:11am
Stock_News_Now @Stock_News_Now
$STXS: New SEC Filing for STXS: Form 8-K (No. 0001493152-19-017171): https://t.co/NNyTBK3uJK
November 14th 2019, 8:11am
StockTexts @StockTexts
$STXS Stereotaxis, Inc. SEC Filing: Form 8-K https://t.co/k8TWeUqHWk
November 14th 2019, 8:11am
MarketCurrents @MarketCurrents
$STXS - Stereotaxis reports Q3 results https://t.co/11KSCl1XSz
November 14th 2019, 8:11am
fintel_io @fintel_io
$STXS / Stereotaxis files form 8-K - Results of Operations and Financial Condition, Financial Statements and Exhibi… https://t.co/BrhS2MpQxJ
November 14th 2019, 8:11am
Gambiste1 @Gambiste1
RT @ErikaWeis1: https://t.co/hcKC0DeVCL $STXS
November 11th 2019, 1:11am
Gambiste1 @Gambiste1
RT @ErikaWeis1: We hope this will benefit health care professionals and their patients.” $STXS
November 11th 2019, 1:11am
Gambiste1 @Gambiste1
RT @ErikaWeis1: The integration of both technologies should result in more effective, rapid, and safe procedures for patients.” $STXS
November 11th 2019, 1:11am
Gambiste1 @Gambiste1
RT @ErikaWeis1: “Life-threatening arrhythmias are common in patients that have suffered a myocardial infarction. $STXS
November 11th 2019, 1:11am
ErikaWeis1 @ErikaWeis1
ST. LOUIS and MT. OLIVE, N.J., Nov. 08, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE American: STXS) and Catheter Precision $STXS
November 11th 2019, 12:11am
ErikaWeis1 @ErikaWeis1
Stereotaxis and Catheter Precision Combine Robotic Navigation and Preoperative Arrhythmia Localization to Treat Cardiac Arrhythmias $STXS
November 11th 2019, 12:11am
ErikaWeis1 @ErikaWeis1
Stereotaxis to Report Third Quarter 2019 Financial Results on November 14, 2019 $STXS
November 11th 2019, 12:11am
ErikaWeis1 @ErikaWeis1
https://t.co/jMZ0qygbIs $STXS
November 11th 2019, 12:11am
ErikaWeis1 @ErikaWeis1
The first integrated procedures were successfully conducted by Dr. Riho Luite of Kuopio University Hospital in Kuopio, Finland. $STXS
November 11th 2019, 12:11am
ErikaWeis1 @ErikaWeis1
This information aids physicians in diagnosing the source of irregular heartbeats and planning cardiac ablation procedures. $STXS
November 11th 2019, 12:11am
ErikaWeis1 @ErikaWeis1
inHEART applies advanced algorithms on preoperative CT and MRI images to generate highly detailed three-dimensional maps of the heart. $STXS
November 11th 2019, 12:11am
ErikaWeis1 @ErikaWeis1
with the integration of inHEART’s advanced preoperative mapping and Stereotaxis’ Robotic Magnetic Navigation technologies. $STXS
November 11th 2019, 12:11am
ErikaWeis1 @ErikaWeis1
Stereotaxis and inHEART Combine Robotic Precision and Advanced Preoperative 3D Mapping to Treat Cardiac Arrhythmias $STXS
November 11th 2019, 12:11am
ErikaWeis1 @ErikaWeis1
https://t.co/hcKC0DeVCL $STXS
November 11th 2019, 12:11am
ErikaWeis1 @ErikaWeis1
We hope this will benefit health care professionals and their patients.” $STXS
November 11th 2019, 12:11am
ErikaWeis1 @ErikaWeis1
The integration of both technologies should result in more effective, rapid, and safe procedures for patients.” $STXS
November 11th 2019, 12:11am
ErikaWeis1 @ErikaWeis1
“Life-threatening arrhythmias are common in patients that have suffered a myocardial infarction. $STXS
November 11th 2019, 12:11am
ErikaWeis1 @ErikaWeis1
The first integrated procedures were successfully conducted by Prof. Pedro Adragao of Hospital da Luz in Lisbon, Portugal. $STXS
November 11th 2019, 12:11am
ErikaWeis1 @ErikaWeis1
ST. LOUIS and BARCELONA, Spain, Nov. 01, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE American: STXS) and ADAS 3D Medical SL $STXS
November 11th 2019, 12:11am
ErikaWeis1 @ErikaWeis1
Stereotaxis and ADAS 3D Combine Robotic Precision and Advanced Preoperative Substrate Mapping to Treat Cardiac Arrhythmias $STXS
November 11th 2019, 12:11am
StockWolfCom @StockWolfCom
$STXS Stereotaxis and Catheter Precision Combine Robotic Navigation and Preoperative Arrhythmia Localization to Tre… https://t.co/4oJxLCsDj0
November 8th 2019, 9:11am
TheTradeXchange @TheTradeXchange
$STXS: Stereotaxis and Catheter Precision Combine Robotic Navigation and Preoperative Arrhythmia Localization to Treat Cardiac Arrhythmias
November 8th 2019, 9:11am
newswithvalue @newswithvalue
$STXS: What Kind Of Investor Owns Most Of Stereotaxis, Inc. (NYSEMKT …: https://t.co/CenT7v4mur
November 7th 2019, 10:11am
StockNewsNow @StockNewsNow
$STXS Stereotaxis to Report Third Quarter 2019 Financial Results on November 14, 2019 https://t.co/45FqnRjwRH
November 6th 2019, 12:11pm
StockWolfCom @StockWolfCom
$STXS Stereotaxis and inHEART Combine Robotic Precision and Advanced Preoperative 3D Mapping to Treat Cardiac Arrhy… https://t.co/mxsd6yp5zZ
November 5th 2019, 9:11am
TheTradeXchange @TheTradeXchange
$STXS: Stereotaxis and inHEART Combine Robotic Precision and Advanced Preoperative 3D Mapping to Treat Cardiac Arrhythmias
November 5th 2019, 9:11am
TheTradeXchange @TheTradeXchange
$STXS: Stereotaxis and ADAS 3D Combine Robotic Precision and Advanced Preoperative Substrate Mapping to Treat Cardiac Arrhythmias
November 1st 2019, 9:11am
TickerReport @TickerReport
Stereotaxis $STXS Stock Crosses Above 200-Day Moving Average of $2.73 https://t.co/QZ5aD2WK82
October 30th 2019, 12:10pm
ConsumerFeed @ConsumerFeed
Brand Asset Management Group Inc. Buys New Stake in Stereotaxis Inc $STXS https://t.co/5rwN9ZHCD2
October 20th 2019, 5:10am
SwingTradeBot @SwingTradeBot
Outside Day today: $STXS ... https://t.co/Ya1wmaeD73
October 18th 2019, 3:10pm
ThisLincolnian @ThisLincolnian
Stereotaxis $STXS Trading Up 9.2% https://t.co/OYIjiPKBH0
October 15th 2019, 11:10pm
confcalltran @confcalltran
Stereotaxis Just Received a Notice of Effectiveness https://t.co/ZY40KIlVcU $STXS
October 7th 2019, 6:10am
FlashAlert_me @FlashAlert_me
$STXS filed form EFFECT on October 07, 00:15:18 https://t.co/ioI4doPdrk
October 7th 2019, 6:10am
Stock_News_Now @Stock_News_Now
$STXS: New SEC Filing for STXS: Form 424B3 (No. 0001493152-19-015086): https://t.co/YweXO3o6f9
October 4th 2019, 5:10pm
fintel_io @fintel_io
$STXS / Stereotaxis files form 424B3 https://t.co/xsASDnH26X
October 4th 2019, 5:10pm
StockTexts @StockTexts
$STXS Stereotaxis, Inc. SEC Filing: Form 424B3 https://t.co/PsR8Mo7COQ
October 4th 2019, 4:10pm
confcalltran @confcalltran
Stereotaxis just filed a prospectus, suggesting it plans to soon issue some securities https://t.co/VIlAZvhb1K $STXS
October 4th 2019, 4:10pm
Toad @Toad
$STXS - possible support here. https://t.co/NikKAZnN7C
October 3rd 2019, 2:10pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.